(Q73517862)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226778%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Hospital pharmacy decisions, cost containment, and the use of cost-effectiveness analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226778%20AND%20SRC:MED&resulttype=core&format=json

cost-effectiveness analysis

4 November 2019

main subject

1 reference

0 references

F. A. Sloan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226778

7 November 2024

K. Whetten-Goldstein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226778

7 November 2024

A. Wilson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226778

7 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9226778

7 November 2024

publication date

1 August 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226778%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

August 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9226778

full work available at URL

7 November 2024

https://api.elsevier.com/content/article/PII:S0277953696003930?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(96)00393-0

https://api.elsevier.com/content/article/PII:S0277953696003930?httpAccept=text/plain

7 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(96)00393-0

Social Science and Medicine

7 November 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226778%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226778%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226778%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

523-533

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226778%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic interchange as a cost-containment measure {editorial}.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900393-0

7 January 2021

The interaction between forms of insurance contract and types of technical change in medical care

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900393-0

7 January 2021

Economic evaluation of standard heparin and enoxaparin for prophylaxis against deep vein thrombosis in elective hip surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900393-0

7 January 2021

The American health care system. Managed care

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900393-0

7 January 2021

Expanding Medicaid drug formulary coverage. Effects on utilization of related services.

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900393-0

7 January 2021

The use of technology assessment by hospitals, health maintenance organizations, and third-party payers in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900393-0

7 January 2021

Hospital drug formularies and use of hospital services

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900393-0

7 January 2021

Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2896%2900393-0

7 January 2021

Controversies in antimicrobial therapy: formulary decisions on third-generation cephalosporins

3

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(96)00393-0

Therapeutic interchange of cefazolin with metronidazole for cefoxitin

7 November 2024

6

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(96)00393-0

How to use structured decision making in developing therapeutic, cost-effective formulary systems

7 November 2024

7

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(96)00393-0

Survey of formulary system policies and procedures

7 November 2024

20

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(96)00393-0

Experience with a two-tiered therapeutic interchange policy

7 November 2024

21

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(96)00393-0

A pharmacoeconomic analysis of IV H2-receptor antagonist use in 40 hospitals

7 November 2024

23

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(96)00393-0

Antimicrobial formulary management: a case study in a teaching hospital

7 November 2024

27

1 reference

https://api.crossref.org/works/10.1016/S0277-9536(96)00393-0

7 November 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226778%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference